DUSLX | RGAFX | DUSLX / RGAFX | |
Total Expense Ratio | 0.18 | 0.34 | 53% |
Annual Report Gross Expense Ratio | 0.18 | 0.34 | 53% |
Fund Existence | 13 years | 23 years | - |
Gain YTD | 8.318 | 11.314 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.8B | 323B | 1% |
Annual Yield % from dividends | 0.96 | 0.57 | 169% |
Returns for 1 year | 14.13 | 11.20 | 126% |
Returns for 3 years | 64.44 | 60.78 | 106% |
Returns for 5 years | 83.37 | 51.12 | 163% |
Returns for 10 years | 193.98 | 88.74 | 219% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYTHX | 206.57 | 2.66 | +1.30% |
Rydex Technology A | |||
CDAZX | 7.71 | 0.05 | +0.65% |
Multi-Manager Directional Alt Strat Inst | |||
MALOX | 20.82 | 0.07 | +0.34% |
BlackRock Global Allocation Instl | |||
AIVFX | 19.55 | -0.01 | -0.05% |
American Funds International Vntg F-2 | |||
ERHSX | 14.05 | -0.03 | -0.21% |
Eaton Vance Worldwide Health Sci R |